ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $863,000 | -20.7% | 26,700 | 0.0% | 0.00% | -25.0% |
Q1 2020 | $1,088,000 | -20.9% | 26,700 | +19.7% | 0.00% | 0.0% |
Q4 2019 | $1,375,000 | -20.7% | 22,300 | -6.3% | 0.00% | -33.3% |
Q3 2019 | $1,735,000 | -8.2% | 23,800 | +3.5% | 0.01% | 0.0% |
Q2 2019 | $1,891,000 | +29.9% | 23,000 | +11.4% | 0.01% | 0.0% |
Q1 2019 | $1,456,000 | +88.1% | 20,646 | +20.0% | 0.01% | +100.0% |
Q4 2018 | $774,000 | +460.9% | 17,200 | +606.1% | 0.00% | +200.0% |
Q3 2018 | $138,000 | – | 2,436 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |